4
Changes in Ownership
BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-19-002873
Senior VP - CCO sold 12,000 shares at an average $9.75 ($116,940)
- Senior VP - CCO acquired 12,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Powell Lynne · Senior VP - CCO
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-01-25 | Exercise or conversion : show line 1 in the form | +6,000 | $3.22 | $19,320 | 6,000 | D |
| 2019-01-25 | Sale : show line 2 in the form | −6,000 | $9.60 | $57,600 | 0 | D |
| 2019-01-28 | Exercise or conversion : show line 3 in the form | +4,000 | $3.22 | $12,880 | 4,000 | D |
| 2019-01-28 | Sale : show line 4 in the form | −4,000 | $9.88 | $39,520 | 0 | D |
| 2019-01-28 | Exercise or conversion : show line 5 in the form | +2,000 | $3.22 | $6,440 | 2,000 | D |
| 2019-01-28 | Sale : show line 6 in the form | −2,000 | $9.91 | $19,820 | 0 | D |
| Open-market sales · 12,000 sh · avg $9.75 · $116,940 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2019-01-25 | Exercise or conversion : show line 7 in the form Emp. Stock Option (Right to Buy) | −6,000 | 85,427 | D |
| 2019-01-28 | Exercise or conversion : show line 8 in the form Emp. Stock Option (Right to Buy) | −4,000 | 81,427 | D |
| 2019-01-28 | Exercise or conversion : show line 9 in the form Emp. Stock Option (Right to Buy) | −2,000 | 79,427 | D |
Loading xslF345X03/form4.xml…